GlaxoSmithKline pulls application for new drug use
Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer. The drug is already sold under the name ...